These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17234160)

  • 21. Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.
    Holzer AK; Katano K; Klomp LW; Howell SB
    Clin Cancer Res; 2004 Oct; 10(19):6744-9. PubMed ID: 15475465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin.
    Servidei T; Ferlini C; Riccardi A; Meco D; Scambia G; Segni G; Manzotti C; Riccardi R
    Eur J Cancer; 2001 May; 37(7):930-8. PubMed ID: 11313183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.
    Holzer AK; Samimi G; Katano K; Naerdemann W; Lin X; Safaei R; Howell SB
    Mol Pharmacol; 2004 Oct; 66(4):817-23. PubMed ID: 15229296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells.
    Katano K; Safaei R; Samimi G; Holzer A; Rochdi M; Howell SB
    Mol Pharmacol; 2003 Aug; 64(2):466-73. PubMed ID: 12869652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profile of copper transporters in sensitive and cisplatin/oxaliplatin-resistant tumor cell lines.
    Kassack MU; Stratenschulte C
    Int J Clin Pharmacol Ther; 2005 Dec; 43(12):597-8. PubMed ID: 16372532
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl.
    Huq F; Daghriri H; Yu JQ; Tayyem H; Beale P; Zhang M
    Eur J Med Chem; 2004 Nov; 39(11):947-58. PubMed ID: 15501544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [[trans-PtCl(NH3)]2mu-[trans-Pd(NH3)(2-hydroxypyridine)-(H2)N(CH2)6NH2)2]Cl4.
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2006 Jul; 41(7):896-903. PubMed ID: 16730394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular localization and trafficking of fluorescein-labeled cisplatin in human ovarian carcinoma cells.
    Safaei R; Katano K; Larson BJ; Samimi G; Holzer AK; Naerdemann W; Tomioka M; Goodman M; Howell SB
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):756-67. PubMed ID: 15701866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
    Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
    Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells.
    Blair BG; Larson CA; Adams PL; Abada PB; Safaei R; Howell SB
    Mol Pharmacol; 2010 Jun; 77(6):912-21. PubMed ID: 20194531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
    Hamad SA; Beale P; Yu JQ; Huq F
    Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compacting effect of BBR3464, a new-generation trisplatinum anticancer agent, on DNA.
    Banerjee T; Dubey P; Mukhopadhyay R
    Biochimie; 2010 Jul; 92(7):846-51. PubMed ID: 20138107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity.
    Cui H; Zhang AJ; McKeage MJ; Nott LM; Geraghty D; Guven N; Liu JJ
    J Inorg Biochem; 2017 Dec; 177():249-258. PubMed ID: 28551160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.
    Dmitriev OY
    Biochem Cell Biol; 2011 Apr; 89(2):138-47. PubMed ID: 21455266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.
    Nakayama K; Kanzaki A; Terada K; Mutoh M; Ogawa K; Sugiyama T; Takenoshita S; Itoh K; Yaegashi N; Miyazaki K; Neamati N; Takebayashi Y
    Clin Cancer Res; 2004 Apr; 10(8):2804-11. PubMed ID: 15102688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of copper transporters in resistance to platinating agents.
    Rabik CA; Maryon EB; Kasza K; Shafer JT; Bartnik CM; Dolan ME
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):133-42. PubMed ID: 18998134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
    Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
    Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A.
    Abada PB; Larson CA; Manorek G; Adams P; Howell SB
    Mol Pharmacol; 2012 Sep; 82(3):510-20. PubMed ID: 22710939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis.
    Lai YH; Kuo C; Kuo MT; Chen HHW
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.